Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?
Mult Scler
.
2021 Nov;27(13):1967-1969.
doi: 10.1177/13524585211049552.
Epub 2021 Oct 6.
Author
Pablo Villoslada
1
Affiliation
1
Stanford University, Stanford, CA, USA/Institut d'Investigacions Biomediques August Pi Sunyer, Barcelona, Spain.
PMID:
34612731
DOI:
10.1177/13524585211049552
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Intermediate Filaments
Multiple Sclerosis* / therapy
Neurofilament Proteins
Precision Medicine
Substances
Neurofilament Proteins